Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at SGD 111.5B, ahead of Johnson & Johnson (SGD 105.2B) and Sanofi (SGD 102.1B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSGD 111.5B
- Median
- SGD 1.1B
- Combined market value
- SGD 6.6T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SGD 111.5B | SGD 208.1B | SGD 36.52 | 0.54% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SGD 105.2B | SGD 858.3B | SGD 356.54 | 0.80% down | 38% up | ||
| 3 | SanofiSNY · Health Care | SGD 102.1B | SGD 146.9B | SGD 61.16 | 0.22% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SGD 67.8B | SGD 447.8B | SGD 181.63 | 1.76% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SGD 67.2B | SGD 233.6B | SGD 134.88 | 0.11% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | SGD 62.8B | SGD 359.7B | SGD 231.90 | 1.34% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SGD 60B | SGD 88.4B | SGD 27.68 | 0.80% down | 54% up | ||
| 8 | NovartisNVS · Health Care | SGD 59.5B | SGD 381.7B | SGD 202.12 | 1.51% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | SGD 40.3B | SGD 128.6B | SGD 1,243.19 | 0.65% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | SGD 37.1B | SGD 227.8B | SGD 51.69 | 1.53% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | SGD 34.2B | SGD 1.61T | SGD 1,806.21 | 1.06% down | 35% up | ||
| 12 | GSKGSK · Health Care | SGD 28B | SGD 126.9B | SGD 63.31 | 0.30% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | SGD 24.1B | SGD 176.1B | SGD 694.52 | 0.81% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | SGD 23.8B | SGD 159B | SGD 77.81 | 1.65% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | SGD 19B | SGD 30.5B | SGD 26.59 | 0.83% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | SGD 12.5B | SGD 50.9B | SGD 88.53 | 0.04% down | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 10.2B | SGD 64B | SGD 54.86 | 0.19% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | SGD 9.2B | SGD 31.7B | SGD 744.81 | 1.12% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SGD 8.4B | SGD 17B | SGD 33.96 | 1.88% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | SGD 7.8B | SGD 14.9B | SGD 77.08 | 2.15% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | SGD 7.5B | SGD 7.5B | SGD 11.06 | 0.63% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | SGD 7.5B | SGD 41.1B | SGD 66.69 | 0.47% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | SGD 5.8B | SGD 36.4B | SGD 50.22 | 0.59% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | SGD 5.6B | SGD 59.9B | SGD 524.69 | 1.55% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 5.6B | SGD 20.1B | SGD 313.40 | 0.96% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 5.2B | SGD 16.1B | SGD 19.35 | 1.39% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | SGD 4.3B | SGD 43.8B | SGD 107.86 | 0.19% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | SGD 2.3B | SGD 10B | SGD 59.43 | 1.40% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | SGD 1.3B | SGD 7.7B | SGD 385.16 | 1.65% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4.1B | SGD 21.07 | 1.40% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.1B | SGD 11.1B | SGD 397.63 | 1.07% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | SGD 1B | SGD 26.8B | SGD 199.77 | 1.02% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | SGD 993.6M | SGD 8.3B | SGD 204.55 | 0.57% up | 31% up | ||
| 34 | InsmedINSM · Health Care | SGD 953M | SGD 34.3B | SGD 156.13 | 0.65% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | SGD 922.4M | SGD 11.7B | SGD 123.61 | 2.17% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | SGD 849.7M | SGD 11.5B | SGD 14.34 | 4.22% up | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | SGD 835.7M | SGD 12.4B | SGD 81.95 | 1.34% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | SGD 835.4M | SGD 9.8B | SGD 89.87 | 0.54% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | SGD 820.7M | SGD 6.4B | SGD 36.96 | 2.91% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | SGD 792.7M | SGD 10.7B | SGD 163.74 | 1.84% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 777.2M | SGD 12.5B | SGD 536.99 | 1.32% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 732M | SGD 9.8B | SGD 124.46 | 1.47% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | SGD 673.5M | SGD 5.9B | SGD 53.71 | 0.93% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | SGD 651.3M | SGD 9.5B | SGD 108.38 | 2.36% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | SGD 636.3M | SGD 6.3B | SGD 112.76 | 0.52% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | SGD 630.7M | SGD 5.8B | SGD 34.87 | 0.30% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | SGD 608.6M | SGD 8.6B | SGD 126.16 | 1.57% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 601M | SGD 8B | SGD 56.37 | 1.67% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | SGD 428.6M | SGD 5.2B | SGD 37.77 | 0.31% down | 169% up | ||
| 50 | ErascaERAS · Health Care | SGD 419.3M | SGD 6.1B | SGD 17.40 | 2.84% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | SGD 405.8M | SGD 7.7B | SGD 118.12 | 0.39% down | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 179.3M | SGD 10.5B | SGD 151.25 | 0.57% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SGD 148.1M | SGD 6.3B | SGD 65.20 | 1.06% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | SGD 113.9M | SGD 9.1B | SGD 173.65 | 0.96% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -SGD 91.3M | SGD 9.7B | SGD 27.74 | 1.85% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -SGD 156.1M | SGD 6.9B | SGD 163.02 | 0.61% up | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -SGD 233M | SGD 22.8B | SGD 347.49 | 0.64% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -SGD 264.8M | SGD 6.5B | SGD 78.24 | 0.51% up | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -SGD 850.7M | SGD 9.4B | SGD 67.30 | 1.05% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -SGD 2.7B | SGD 19.5B | SGD 100.13 | 1.09% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -SGD 4.2B | SGD 660.2B | SGD 373.51 | 1.09% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2896 SGD).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (SGD 111.5B), Johnson & Johnson (SGD 105.2B) and Sanofi (SGD 102.1B) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 15:14 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of SGD 6.6T as of 18 Nov 2026, 15:14 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.